Averhealth, a substance use monitoring and treatment services provider, with the backing of Five Arrows Capital Partners, has acquired Vermont-based healthcare company Aspenti for an undisclosed price.

Aspenti is a specialist in substance use monitoring and care coordination services for patients of physicians, healthcare systems, and treatment centers.

Jason Herzog – CEO of Averhealth said: “The acquisition of Aspenti broadens Averhealth’s referral base to include physicians, treatment centers and healthcare systems.

“Aspenti’s social mission of promoting positive change, improving well-being and creating a better world perfectly aligns with Averhealth’s mission of reclaiming lives, uniting families and strengthening communities. This is a perfect fit for us as we advance our goal of improving patient outcomes for those struggling with substance use disorder.”

Established in 2017, Aspenti offers healthcare services and diagnostic testing for addressing population health for substance use management.

Chris Powell – CEO of Aspenti said: “With Averhealth acquiring Aspenti, it fosters long-term sustainable growth for our colleagues, patients and partners. Both companies are dedicated to delivering continuity of care and exemplary customer service that we both value.

“As a purpose driven company, Averhealth’s mission, vision, and values will foster and continue Aspenti’s work of being a steward of change in substance use management and the greater healthcare industry.”

  Averhealth, Chris Powell, Five Arrows Capital Partners, Jason Herzog, substance use disorder, USA, Vermont